Subtype
Liver Neoplasm
CI-CAN-00001077Explore in graph →
Non-malignant930 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001077Explore in graph →
Clinical trials
4,334 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00681499 | Quality of Life After Liver Resection | completed | — | 198 | University of BernOTHER | 1 | Nov 13, 2015 | clinicaltrials |
| NCT00980239 | HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | completed | Phase 1 | 115 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT01798160 | Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). | completed | Phase 4 | 24 | Johannes Gutenberg University MainzOTHER | 0 | Oct 20, 2015 | clinicaltrials |
| NCT02044224 | Effects of Dexmedetomidine During IRE Procedures for Solid Tumours | completed | Phase 4 | 30 | Uppsala University HospitalOTHER | 1 | Oct 20, 2015 | clinicaltrials |
| NCT02578602 | MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer | completed | Phase 1 | 26 | University of Southern CaliforniaOTHER | 1 | Oct 19, 2015 | clinicaltrials |
| NCT00739167 | Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer | completed | — | 74 | Northwestern UniversityOTHER | 1 | Oct 16, 2015 | clinicaltrials |
| NCT00524498 | A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma | completed | Phase 2 | 60 | Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT01549275 | Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration | completed | — | 105 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT01012011 | Regulatory Post Marketing Surveillance Study on Nexavar® | completed | — | 2,845 | BayerINDUSTRY | 1 | Sep 21, 2015 | clinicaltrials |
| NCT01641276 | Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma(THBC-HSL2) | completed | N/A | 60 | Hospital Sirio-LibanesOTHER | 1 | Sep 14, 2015 | clinicaltrials |
| NCT01686412 | Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency | completed | N/A | 60 | Hospital Sirio-LibanesOTHER | 1 | Sep 14, 2015 | clinicaltrials |
| NCT02338778 | Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient | completed | Phase 1 / Phase 2 | 20 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 10, 2015 | clinicaltrials |
| NCT00604409 | Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer | completed | Phase 1 | 34 | Fox Chase Cancer CenterOTHER | 1 | Sep 7, 2015 | clinicaltrials |
| NCT02541149 | Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma | completed | — | 90 | Ain Shams UniversityOTHER | 0 | Sep 4, 2015 | clinicaltrials |
| NCT00131937 | Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma | completed | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Sep 3, 2015 | clinicaltrials |
| NCT02539212 | Comparison of Microwave and Radiofrequency Ablation for Liver | completed | N/A | 403 | Chinese PLA General HospitalOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02041065 | Waterjet Versus Ultrasound Dissection During Hepatic Transection | completed | Phase 2 | 84 | Karolinska University HospitalOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT01612325 | Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases(HEPAR-2) | completed | Phase 2 | 56 | UMC UtrechtOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT00902343 | Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection | completed | Phase 3 | 149 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01658319 | Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies | completed | Phase 1 | 20 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01959477 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | completed | Early Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02014025 | Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC | completed | N/A | 335 | Shuguo Zheng, MDOTHER | 1 | Aug 11, 2015 | clinicaltrials |
| NCT00997022 | Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients | completed | Phase 1 | 14 | Columbia UniversityOTHER | 1 | Aug 10, 2015 | clinicaltrials |
| NCT02329821 | Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection | completed | — | 72 | Samsung Medical CenterOTHER | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00365391 | Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer | completed | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2015 | clinicaltrials |
| NCT01738217 | Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery(HEPATOFLUO) | completed | Phase 1 / Phase 2 | 48 | Centre Leon BerardOTHER | 1 | Jul 8, 2015 | clinicaltrials |
| NCT00608361 | Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT02201797 | Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body | completed | N/A | 13 | Asan Medical CenterOTHER | 1 | Jun 24, 2015 | clinicaltrials |
| NCT00482586 | Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy | completed | — | 137 | Vanderbilt UniversityOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01406574 | Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 23 | Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT02089919 | Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02454686 | Fibroscan Predicts Complications After Hepatectomy(Fibroscan) | completed | — | 240 | University of MilanOTHER | 0 | May 27, 2015 | clinicaltrials |
| NCT01332669 | Drug-eluting Bead in Hepatocellular Carcinoma(REDEBUT) | completed | Phase 4 | 200 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT01519232 | A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT) | completed | — | 23 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT00493883 | Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors | completed | Phase 1 / Phase 2 | 81 | Southwestern Regional Medical CenterOTHER | 1 | May 13, 2015 | clinicaltrials |
| NCT00030082 | Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00020150 | Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00107536 | Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00006016 | Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01785212 | The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver | completed | N/A | 40 | Medical University of ViennaOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT01003015 | Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma | completed | Phase 2 | 36 | BayerINDUSTRY | 4 | Apr 3, 2015 | clinicaltrials |
| NCT02404909 | Inferior Vena Cava Index in Patients Undergoing Liver Resection(IVC) | completed | — | 91 | University of MilanOTHER | 0 | Apr 1, 2015 | clinicaltrials |
| NCT00831844 | Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 3 | Mar 30, 2015 | clinicaltrials |
| NCT00844168 | Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant | completed | Phase 1 | 4 | University of WashingtonOTHER | 1 | Mar 27, 2015 | clinicaltrials |
| NCT00056992 | Testing of ADI-PEG in Hepatocellular Carcinoma | completed | Phase 2 | 34 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT02113865 | Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients | completed | — | 45 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01203787 | Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC) | completed | Phase 4 | 120 | University of FloridaOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01411436 | Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan | completed | — | 1,637 | BayerINDUSTRY | 1 | Mar 4, 2015 | clinicaltrials |
| NCT00355355 | A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 3 | 208 | Light Sciences OncologyINDUSTRY | 11 | Jan 30, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Nov 13, 2015source: clinicaltrials